Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: A Full Face Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Addition with MG-CLR Serum for Acne Treatment Over 12 Weeks. [Phase 2, Phase 3]

View source ↗

Summary

This document describes a Phase 2/Phase 3 clinical trial evaluating the Dermapen 4 microneedling device in combination with MG-CLR Serum for acne over 12 weeks,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dermapen 4 microneedling device
  • MG-CLR Serum

Snippet

Sponsor: Equipmed USA LLC | Conditions: Acne | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING